Keywords: Alk-Abello, Torri Pharma, Allergy, Asthma, Mitizax, Alutard, License, Japan

Alk-Abello in up to 60 million-euro deal with Torii for allergy products in Japan

Article | 08 February 2011

Print This

Danish drugmaker Alk-Abello (ALKB: DC) has entered into an exclusive license agreement with Japan’s Torii Pharmaceuticals (TSE: 4551) to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in